$7.68 Billion is the total value of NEA Management Company, LLC's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 19.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHG | New | BRIGHT HEALTH GROUP INC | $3,744,520,000 | – | 218,212,128 | +100.0% | 48.77% | – |
| COUR | Sell | COURSERA INC | $656,817,000 | -31.0% | 16,603,063 | -21.5% | 8.56% | -60.0% |
| NET | CLOUDFLARE INC | $292,498,000 | +50.6% | 2,763,583 | 0.0% | 3.81% | -12.6% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $257,405,000 | +32.9% | 1,590,002 | 0.0% | 3.35% | -22.9% | |
| DM | Sell | DESKTOP METAL INC | $223,222,000 | -47.3% | 19,410,631 | -31.7% | 2.91% | -69.4% |
| ALLK | ALLAKOS INC | $184,801,000 | -25.6% | 2,164,704 | 0.0% | 2.41% | -56.8% | |
| EAR | Sell | EARGO INC | $180,420,000 | -44.6% | 4,520,670 | -30.7% | 2.35% | -67.9% |
| GLUE | New | MONTE ROSA THERAPEUTICS INC | $174,863,000 | – | 7,703,205 | +100.0% | 2.28% | – |
| ARDX | ARDELYX INC | $103,343,000 | +14.5% | 13,633,582 | 0.0% | 1.35% | -33.6% | |
| BILL | New | BILL COM HLDGS INC | $102,723,000 | – | 560,774 | +100.0% | 1.34% | – |
| OYST | OYSTER PT PHARMA INC | $101,856,000 | -6.0% | 5,925,287 | 0.0% | 1.33% | -45.4% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $96,183,000 | -7.9% | 4,912,306 | 0.0% | 1.25% | -46.6% | |
| NKTX | NKARTA INC | $92,059,000 | -3.7% | 2,904,974 | 0.0% | 1.20% | -44.1% | |
| MILE | METROMILE INC | $85,866,000 | -11.1% | 9,384,295 | 0.0% | 1.12% | -48.4% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $72,772,000 | -19.8% | 17,082,611 | 0.0% | 0.95% | -53.4% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $72,407,000 | -12.8% | 4,187,801 | 0.0% | 0.94% | -49.4% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $67,038,000 | -0.2% | 5,172,683 | 0.0% | 0.87% | -42.1% | |
| CVRX | New | CVRX INC | $66,384,000 | – | 2,370,858 | +100.0% | 0.86% | – |
| OPEN | Sell | OPENDOOR TECHNOLOGIES INC | $59,090,000 | -58.2% | 3,333,276 | -50.0% | 0.77% | -75.7% |
| ANNX | ANNEXON INC | $56,222,000 | -19.1% | 2,497,661 | 0.0% | 0.73% | -53.1% | |
| TRILLIUM THERAPEUTICS INC | $55,643,000 | -9.7% | 5,736,363 | 0.0% | 0.72% | -47.6% | ||
| AKUS | AKOUOS INC | $53,946,000 | -9.5% | 4,298,488 | 0.0% | 0.70% | -47.5% | |
| VTGN | VISTAGEN THERAPEUTICS INC | $51,353,000 | +47.9% | 16,302,596 | 0.0% | 0.67% | -14.1% | |
| CSPR | CASPER SLEEP INC | $51,303,000 | +13.8% | 6,226,130 | 0.0% | 0.67% | -34.0% | |
| RPHM | New | RENEO PHARMACEUTICALS INC | $44,662,000 | – | 4,786,921 | +100.0% | 0.58% | – |
| GRTX | GALERA THERAPEUTICS INC | $42,888,000 | +11.4% | 4,362,986 | 0.0% | 0.56% | -35.3% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $42,054,000 | -49.8% | 3,449,845 | 0.0% | 0.55% | -70.8% | |
| INZY | INOZYME PHARMA INC | $41,652,000 | -13.9% | 2,444,379 | 0.0% | 0.54% | -50.0% | |
| SVRA | SAVARA INC | $41,034,000 | -18.3% | 24,137,931 | 0.0% | 0.53% | -52.6% | |
| AFMD | Sell | AFFIMED NV | $37,625,000 | -12.0% | 4,426,488 | -18.1% | 0.49% | -49.0% |
| BE | BLOOM ENERGY CORP | $35,827,000 | -0.7% | 1,333,333 | 0.0% | 0.47% | -42.3% | |
| UPST | Sell | UPSTART HLDGS INC | $35,858,000 | -51.5% | 287,092 | -49.9% | 0.47% | -71.8% |
| VRNA | VERONA PHARMA PLCads | $33,410,000 | -21.8% | 5,108,563 | 0.0% | 0.44% | -54.6% | |
| IMRA | IMARA INC | $31,736,000 | -6.4% | 4,017,170 | 0.0% | 0.41% | -45.7% | |
| MRKR | MARKER THERAPEUTICS INC | $29,893,000 | +24.6% | 10,714,285 | 0.0% | 0.39% | -27.8% | |
| AVEO | AVEO PHARMACEUTICALS INC | $26,050,000 | -10.0% | 3,952,958 | 0.0% | 0.34% | -47.8% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $24,715,000 | +7.5% | 6,643,704 | 0.0% | 0.32% | -37.6% | |
| MEIP | MEI PHARMA INC | $24,319,000 | -16.9% | 8,533,072 | 0.0% | 0.32% | -51.8% | |
| GNCA | GENOCEA BIOSCIENCES INC | $24,282,000 | -13.7% | 10,376,936 | 0.0% | 0.32% | -49.9% | |
| STSA | Buy | SATSUMA PHARMACEUTICALS INC | $22,158,000 | +25.1% | 3,142,958 | +4.8% | 0.29% | -27.4% |
| GLYC | GLYCOMIMETICS INC | $21,087,000 | -22.9% | 9,089,041 | 0.0% | 0.28% | -55.2% | |
| GERN | GERON CORP | $18,981,000 | -10.8% | 13,461,538 | 0.0% | 0.25% | -48.2% | |
| XENE | XENON PHARMACEUTICALS INC | $18,473,000 | +4.0% | 992,107 | 0.0% | 0.24% | -39.6% | |
| CTIC | CTI BIOPHARMA CORP | $17,851,000 | -14.1% | 7,140,450 | 0.0% | 0.23% | -50.0% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $17,617,000 | -9.0% | 1,713,720 | 0.0% | 0.23% | -47.4% | |
| ADXN | New | ADDEX THERAPEUTICS LTDsponsored ads | $17,208,000 | – | 180,000 | +100.0% | 0.22% | – |
| SYBX | SYNLOGIC INC | $16,452,000 | +8.7% | 4,229,410 | 0.0% | 0.21% | -37.1% | |
| IVA | INVENTIVA SAads | $14,208,000 | -7.2% | 1,041,666 | 0.0% | 0.18% | -46.2% | |
| OBSV | OBSEVA SA | $13,897,000 | -6.8% | 4,586,563 | 0.0% | 0.18% | -46.0% | |
| TRVI | TREVI THERAPEUTICS INC | $13,367,000 | -17.0% | 5,940,796 | 0.0% | 0.17% | -51.8% | |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $12,300,000 | +7.6% | 4,141,308 | 0.0% | 0.16% | -37.7% | |
| MTCR | METACRINE INC | $11,639,000 | -38.7% | 3,062,977 | 0.0% | 0.15% | -64.3% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $10,935,000 | -21.8% | 2,382,286 | 0.0% | 0.14% | -54.8% | |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $7,110,000 | +6.3% | 2,486,062 | 0.0% | 0.09% | -38.0% | |
| TRVN | TREVENA INC | $6,442,000 | -5.6% | 3,811,691 | 0.0% | 0.08% | -45.1% | |
| LUMO | LUMOS PHARMA INC | $5,267,000 | -14.5% | 526,663 | 0.0% | 0.07% | -50.0% | |
| RGLS | REGULUS THERAPEUTICS INC | $5,225,000 | -48.1% | 6,451,056 | 0.0% | 0.07% | -69.9% | |
| ERYP | ERYTECH PHARMA SAadr | $3,019,000 | -31.4% | 625,000 | 0.0% | 0.04% | -60.6% | |
| TCON | TRACON PHARMACEUTICALS INC | $2,250,000 | -92.1% | 346,718 | 0.0% | 0.03% | -95.5% | |
| TPST | New | TEMPEST THERAPEUTICS INC | $1,317,000 | – | 117,785 | +100.0% | 0.02% | – |
| AKTX | AKARI THERAPEUTICS PLCadr | $782,000 | -34.5% | 452,167 | 0.0% | 0.01% | -63.0% | |
| VECT | New | VECTIVBIO HLDG AG | $782,000 | – | 67,069 | +100.0% | 0.01% | – |
| VIRX | VIRACTA THERAPEUTICS INC | $421,000 | +22.7% | 37,093 | 0.0% | 0.01% | -37.5% | |
| DZSI | Exit | DZS INC | $0 | – | -38,470 | -100.0% | -0.01% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -1,766,779 | -100.0% | -0.05% | – |
| SPT | Exit | SPROUT SOCIAL INC | $0 | – | -1,545,040 | -100.0% | -2.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.